Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€14.71
23.02.24
-
23.02.25
6.05%
02.03.24

nero 
23.02.24 0%
buy
Repligen Corp.

Start price
Target price
Perf. (%)
€178.80
22.02.24
€191.27
22.02.25
-38.09%
08.07.24

Stifel Nicolaus 
22.02.24 50%
buy
Ionis Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€40.65
22.02.24
€58.21
22.02.25
7.08%
11.07.24

Piper Sandler 
22.02.24 50%
buy
United Therapeutics

Start price
Target price
Perf. (%)
€202.00
22.02.24
€277.11
22.02.25
47.62%
11.07.24

HC Wainwright 
22.02.24 50%
buy
Ionis Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€40.10
22.02.24
€55.42
22.02.25
8.55%
11.07.24

Needham & Company LLC 
22.02.24 50%
buy
United Therapeutics

Start price
Target price
Perf. (%)
€202.00
22.02.24
€284.50
22.02.25
47.62%
11.07.24

Wedbush 
22.02.24 50%
sell
Fibrogen Inc.

Start price
Target price
Perf. (%)
€1.55
22.02.24
-
22.02.25
4.52%
02.03.24

Very low/no dividend yield expected
Risky Investment
EBIT decline/stagnation expected
High valuation
kostojunior 
22.02.24 0%
sell
Emergent Biosolutions Inc.

Start price
Target price
Perf. (%)
€2.38
21.02.24
-
21.02.25
30.70%
01.03.24

Bankster 
21.02.24 50%
sell
Emergent Biosolutions Inc.

Start price
Target price
Perf. (%)
€2.86
21.02.24
-
21.02.25
8.94%
02.03.24

Good culture
Probably not worthwhile Investment
No uniques
me8 
21.02.24 0%
sell
Emergent Biosolutions Inc.

Start price
Target price
Perf. (%)
€2.86
21.02.24
-
21.02.25
9.43%
01.03.24

michaelkr 
21.02.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€138.00
21.02.24
-
21.02.25
74.20%
11.07.24

StockNews.com 
21.02.24 50%
buy
Halozyme Therapeutics Inc.

Start price
Target price
Perf. (%)
€35.80
21.02.24
€46.24
21.02.25
35.84%
11.07.24

HC Wainwright 
21.02.24 50%
buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€11.70
20.02.24
€20.35
20.02.25
-33.64%
11.07.24

Wells Fargo & Company 
20.02.24 50%
buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€11.80
20.02.24
€17.55
20.02.25
-34.20%
11.07.24

The Goldman Sachs Group, Inc. 
20.02.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€137.40
20.02.24
€217.07
20.02.25
74.96%
11.07.24

Royal Bank of Canada 
20.02.24 50%
buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€11.80
20.02.24
€16.63
20.02.25
-34.20%
11.07.24

Piper Sandler 
20.02.24 50%
buy
Iovance Biotherapeutics Inc.

Start price
Target price
Perf. (%)
€10.58
20.02.24
€31.41
20.02.25
-26.62%
11.07.24

Chardan Capital 
20.02.24 50%
sell
Fibrogen Inc.

Start price
Target price
Perf. (%)
€2.14
19.02.24
-
19.02.25
-24.30%
02.03.24

Wolf_of_WS 
19.02.24 50%
buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€2.14
19.02.24
-
19.02.25
-24.30%
03.03.24

Probably not worthwhile Investment
thomasw 
19.02.24 50%
buy
Fibrogen Inc.

Start price
Target price
Perf. (%)
€2.14
19.02.24
€6.00
31.07.27
-44.67%
26.05.24

Could be very worthwhile Investment >20% year
BiotechBee 
19.02.24 60%
sell
Ionis Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€41.07
17.02.24
-
17.02.25
5.99%
11.07.24

StockNews.com 
17.02.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€136.40
16.02.24
€210.72
16.02.25
76.25%
11.07.24

Citigroup Inc. 
16.02.24 50%
buy
Agios Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€24.80
16.02.24
€38.99
16.02.25
65.32%
11.07.24

Royal Bank of Canada 
16.02.24 50%
buy
Ironwood Pharmaceuticals

Start price
Target price
Perf. (%)
€13.50
16.02.24
€19.49
16.02.25
-57.04%
10.07.24

Piper Sandler 
16.02.24 50%
buy
Alnylam Pharmace.

Start price
Target price
Perf. (%)
€139.00
16.02.24
€209.30
16.02.25
72.95%
11.07.24

Chardan Capital 
16.02.24 50%